BURLINGTON, N.C., Feb. 24, 2025 /PRNewswire/ -- Labcorp (NYSE: LH), a global leader of innovative and comprehensive laboratory services, announced today the clinical availability of Labcorp® Plasma ...
GlobalData on MSN
NAMSA acquires Labcorp’s medical device testing assets
NAMSA has acquired select assets of Labcorp’s early development medical device testing business, aligning with .
Labcorp (NYSE:LH) announced Wednesday that the U.S. Food and Drug Administration (FDA) granted emergency use authorization for its Mpox PCR Test Home Collection Kit, which can be used to detect the ...
NAMSA, a global leader in medical device testing, clinical research, and regulatory consulting, is pleased to announce it has ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback